BioLife Solutions (BLFS) 10-Q2015 Q1 Quarterly report

Filed: 7 May 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Aby, animal, arise, ASC, Australian, bank, BBB, began, behalf, book, cardiac, caution, cautionary, cautioned, cease, chain, CHD, Cold, Compliance, congenital, deployed, deploying, dermal, dextran, directly, discretion, Distinguished, drawn, driven, embedded, enhancement, entirety, essentially, exit, expressly, external, feasibility, founding, frozen, Global, GMP, grant, granted, granting, growth, guarantee, headcount, heart, history, inaccurate, indefinitely, inference, intangible, interal, ischemia, Kevin, law, leukemia, limb, liver, low, Mathew, maturity, Mayo, melanoma, mobile, newly, obtaining, occurrence, October, oral, orderly, ordinary, outcome, Parenteral, payload, payroll, pediatric, porcine, publicly, qualified, range, reached, ready, real, recruitment, regeneration, reliance, renal, replace, resigning, response, room, safe, safety, Seattle, sensitive, shortage, Silver, size, sophisticated, speak, standard, streaming, umbilical, unanticipated, underlying, undue, unknown, validation, web, written

Removed: ability, absence, accrual, accrued, achieve, acquire, adversely, affecting, ag, allocated, aseptic, authorized, automatically, Baust, cancelled, certificate, closed, competition, concurrently, consisted, converted, depend, develop, event, Excluding, execute, expired, expressed, extinguished, family, February, fee, finance, forfeited, generate, GmbH, goal, holding, identify, impact, implied, incorporation, increasing, integral, investor, issuing, John, June, leased, license, Licensing, limit, limitation, liquid, listed, litigation, minimum, monitor, nasdaq, negotiated, noted, notice, opportunity, originally, party, payment, preservation, prior, promissory, ratio, recognized, renew, rentable, restructuring, resulted, resulting, reverse, security, send, solution, split, state, strategic, successfully, successive, symbol, uneven, unit, upfront, warrant, WAVI, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BLFS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioLife Solutions, Inc. (the “Company”) on Form 10-Q for the three month period ended March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daphne Taylor, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2015

	/s/ Daphne Taylor
	Daphne Taylor
	Chief Financial Officer